Sandy Spring Bank’s Pfizer PFE Stock Holding History

Sandy Spring Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$852K	Sell	33,612 -1,874	-5%	-$49K	0.04%	239
2024 Q4	$941K	Sell	35,486 -2,650	-7%	-$71.9K	0.04%	238
2024 Q3	$1.1M	Sell	38,136 -3,573	-9%	-$104K	0.05%	219
2024 Q2	$1.17M	Sell	41,709 -13,506	-24%	-$372K	0.05%	210
2024 Q1	$1.53M	Sell	55,215 -9,946	-15%	-$276K	0.07%	180
2023 Q4	$1.88M	Sell	65,161 -13,885	-18%	-$420K	0.09%	163
2023 Q3	$2.62M	Sell	79,046 -11,425	-13%	-$404K	0.15%	134
2023 Q2	$3.32M	Sell	90,471 -5,536	-6%	-$215K	0.18%	120
2023 Q1	$3.92M	Buy	96,007 +578	+0.6%	+$25K	0.22%	104
2022 Q4	$4.89M	Sell	95,429 -5,998	-6%	-$288K	0.29%	87
2022 Q3	$4.44M	Sell	101,427 -8,685	-8%	-$422K	0.28%	95
2022 Q2	$5.77M	Buy	110,112 +3,593	+3%	+$183K	0.35%	74
2022 Q1	$5.51M	Sell	106,519 -243	-0.2%	-$12.6K	0.28%	90
2021 Q4	$6.3M	Sell	106,762 -7,599	-7%	-$377K	0.3%	82
2021 Q3	$4.92M	Buy	114,361 +7,819	+7%	+$346K	0.26%	95
2021 Q2	$4.17M	Sell	106,542 -3,828	-3%	-$149K	0.22%	107
2021 Q1	$4M	Sell	110,370 -4,906	-4%	-$174K	0.23%	108
2020 Q4	$4.24M	Sell	115,276 -2,995	-3%	-$110K	0.26%	99
2020 Q3	$4.12M	Buy	118,271 +5,012	+4%	+$176K	0.28%	93
2020 Q2	$3.51M	Buy	113,259 +5,803	+5%	+$197K	0.26%	95
2020 Q1	$3.33M	Sell	107,456 -127	-0.1%	-$4.33K	0.3%	87
2019 Q4	$4M	Buy	107,583 +562	+0.5%	+$20K	0.29%	87
2019 Q3	$3.65M	Buy	107,021 +3,884	+4%	+$141K	0.28%	87
2019 Q2	$4.24M	Buy	103,137 +1,443	+1%	+$57.3K	0.34%	79
2019 Q1	$4.1M	Sell	101,694 -8,034	-7%	-$322K	0.35%	79
2018 Q4	$4.54M	Sell	109,728 -5,977	-5%	-$248K	0.44%	61
2018 Q3	$4.84M	Sell	115,705 -9,178	-7%	-$353K	0.4%	67
2018 Q2	$4.3M	Sell	124,883 -1,899	-1%	-$64.9K	0.37%	72
2018 Q1	$4.27M	Sell	126,782 -3,480	-3%	-$120K	0.38%	66
2017 Q4	$4.48M	Buy	130,262 +2,430	+2%	+$82.9K	0.41%	62
2017 Q3	$4.33M	Buy	127,832 +4,105	+3%	+$132K	0.41%	63
2017 Q2	$3.94M	Buy	123,727 +2,564	+2%	+$80.9K	0.39%	65
2017 Q1	$3.93M	Sell	121,163 -1,628	-1%	-$51.3K	0.39%	65
2016 Q4	$3.78M	Buy	122,791 +1,338	+1%	+$40.8K	0.39%	63
2016 Q3	$3.9M	Buy	121,453 +1,411	+1%	+$47.2K	0.42%	59
2016 Q2	$4.02M	Sell	120,042 -23,862	-17%	-$762K	0.46%	57
2016 Q1	$4.05M	Buy	143,904 +25,297	+21%	+$723K	0.46%	59
2015 Q4	$3.63M	Sell	118,607 -4,870	-4%	-$153K	0.42%	67
2015 Q3	$3.68M	Sell	123,477 -5,929	-5%	-$190K	0.45%	64
2015 Q2	$4.12M	Buy	129,406 +75	+0.1%	+$2.44K	0.47%	62
2015 Q1	$4.27M	Buy	129,331 +14,181	+12%	+$451K	0.5%	62
2014 Q4	$3.4M	Buy	115,150 +10,930	+10%	+$313K	0.41%	72
2014 Q3	$2.92M	Sell	104,220 -685	-0.7%	-$19.2K	0.36%	84
2014 Q2	$2.96M	Buy	104,905 +7,348	+8%	+$209K	0.37%	78
2014 Q1	$2.97M	Sell	97,557 -2,770	-3%	-$82.6K	0.46%	71
2013 Q4	$2.92M	Sell	100,327 -1,419	-1%	-$41.3K	0.41%	78
2013 Q3	$2.77M	Sell	101,746 -836	-0.8%	-$22.7K	0.41%	77
2013 Q2	$2.73M	Buy	+102,582	New	+$2.83M	0.43%	73

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sandy Spring Bank's PFE Position: Q1 2025 in Review

Sandy Spring Bank reduced its Pfizer (PFE) stake by 5.3% in Q1 2025, selling an estimated $49K and leaving 33,612 shares worth $852K. The position accounts for 0.04% of the portfolio, ranked #239.

Sandy Spring Bank first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $6.3M in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Sandy Spring Bank held 33,612 shares of Pfizer worth $852K as of Q1 2025.
Sandy Spring Bank sold 1,874 Pfizer shares in Q1 2025, an estimated $49K.
Pfizer made up 0.04% of Sandy Spring Bank's portfolio in Q1 2025, its #239 holding.
Sandy Spring Bank first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
Sandy Spring Bank's Pfizer position peaked at $6.3M in Q4 2021.
2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.